First Header Logo Second Header Logo

Connection

Peter Clark to Anticarcinogenic Agents

This is a "connection" page, showing publications Peter Clark has written about Anticarcinogenic Agents.
Connection Strength

0.274
  1. Clark PE, Hall MC, Borden LS, Miller AA, Hu JJ, Lee WR, Stindt D, D'Agostino R, Lovato J, Harmon M, Torti FM. Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy. Urology. 2006 Jun; 67(6):1257-61.
    View in: PubMed
    Score: 0.274
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.